Endocrine Aspects of Pregnancy and Parturition
Adrenal Cortex and Pregnancy by C L Cope DM (London) That the adrenal cortex tends to enlarge during pregnancy has been known for a great many years. It has been known, too, since the work of Venning in 1946, that the amount of active adrenal cortical hormone in the urine is increased in late pregnancy, as judged by bioassay of urinary extracts.
This we were able to confirm some years later.
It will be recalled that Hench etval. (1949) had attributed the clinical improvement seen in pregnant rheumatoid arthritics to an assumed increase in adrenal activity based on these and similar observations. When it was recognized that the active hormone was in fact cortisol and chemical methods of estimating this were worked out, it was found that the level of plasma cortisol rose progressively during pregnancy, reaching the highest peak at the time of labour (Bayliss et al. 1955 ). This raised several fundamental problems: (1) Was the rise due to increased production of cortisol by the adrenal or was it due to reduced rate of destruction? (2) Was there any formation of cortisol at another site, such for instance as the placenta? (3) Why was there no clinical development of cushingoid features or other evidences of hypercorticism as a result of the raised plasma levels ?
(1) It might be thought that the question of increased production could have been solved by some of the widely used indices of adrenal function-some of the urinary steroid analyses. The fact that no firm conclusion has been reached by this means, and indeed that two schools of thought persist, is surely a reflection of the unreliability of such tests-for revealing moderate changes in adrenal activity.
The availability of isotope-labelled steroids has made it possible to solve this problem. By administering a dose of the isotopic cortisol, and observing the extent to which this is diluted by 46 admixture with the non-isotopic cortisol of endogenous origin, the daily production of cortisol by the body can be calculated. Observations in late pregnancy made in a series of cases show a mean cortisol production rate of about 25 mg daily, compared with a mean of about 11 mg daily for a group of non-pregnant women of the same age range (Cope & Black 1959) . It is interesting to note how well those estimates, derived from isotopic techniques, agree with estimates derived by purely clinical observation. Patients with Addison's disease have been successfully brought to full term on doses of cortisone acetate varying from 10 to 50 mg daily. Most require about 25 mg daily and one patient who was allowed to choose her own dose developed clear signs of overdosage on 50 mg daily. Isotopic methods have also shown that the daily production of aldosterone is increased in pregnancy to about three times the non-pregnant level (Jones et al. 1959 ).
(2) Several groups have shown that injected cortisol, whether natural or isotopic, disappears at about half the normal speed in women in late pregnancy (Migeon et al. 1957 ).
(3) The lack of hyperadrenal symptoms is explained by the finding that the greater part of the circulating cortisol is bound to protein and is probably thereby temporarily inactivated. The proportion bound is greatly increased in pregnancy, and the rise in binding protein is found to be produced by estrogens, either natural or synthetic (Mills & Bartter 1959 , Taliaferro et al. 1956 ).
Maternal circulating cortisol crosses the placenta into the foetus fairly readily and the products of its metabolism equally readily pass out of the foetus into the maternal venous system. Whether the placenta itself manufactures any cortisol is as yet unknown, but if it does the amount is likely to be relatively small. Metabolites derived from cortisol are only found in the urine in trace or very small amounts when steroid therapy is withheld from a pregnant addisonian patient.
Thus in pregnancy there appears to be (a) In- In this communication I shall confine myself to a brief consideration of the main problems of diabetic pregnancy from the physician's viewpoint and leave the presentation of results to Sir John Peel. The chief problem is the feetal loss rate, maternal mortality being now almost as low as that in normal women; maternal morbidity is another matter. The suitability of any diabetic woman to embark on pregnancy may be viewed from the standpoint of heredity, maternal morbidity or in relation to the outcome of the pregnancy. The diabetic status has usually been considered chiefly in relation to the probability of the production of a live child which survives, but it is important to take into account the effects of pregnancy on the diabetic mother. In a personal series of 275 diabetic pregnancies the effect of the pregnancy was investigated in relation to: (1) subsequent insulin requirement, (2) retinopathy, (3) hypertension, and (4) albuminuria. In a few cases the insulin requirement was greater and in a few less than before pregnancy but in the last 80 consecutive pregnancies of this series there was no significant increase in insulin requirement. In 2 patients there was severe atypical retinopathy with hemorrhages and papilleedema which cleared completely after delivery, and in 2 patients typical retinopathy progressed during and immediately after pregnancy. In 10 patients with retinopathy there was no evidence of progression. These results are too scanty to allow conclusions to be drawn, but it seems that pregnancy must be regarded as potentially dangerous in those diabetics with the vascular or pre-retinal lesions which so often give rise to vitreous hemorrhage and retinitis proliferans.
Hypertension and albuminuria were considered in relation to toxemia of pregnancy, of which the incidence has fallen in the past three years at King's College Hospital. In a consecutive series of 222 diabetic pregnancies, 24 were complicated by toxEemia. Three of these 24 were untraced, 1 mother died with eclamptic fits and cholaemia, and 1 had uremia due to chronic nephritis. In 13 of the remaining 19 cases there was no evidence of change following the toxemic pregnancy. In the other 6 cases there was a significant rise in blood pressure in 3 and albuminuria in 1; 2 developed retinopathy. As the minimum duration of the diabetes in these cases was ten years, and the interval between the toxaemic pregnancy and the follow-up examination varied from one to eight years, it is impossible to assess the significance, if any, of toxaemia of pregnancy in relation to the incidence of subsequent complications. The effect of the diabetic status on the outcome of the pregnancy is based on a series of 733 pregnancies. The severity of the maternal diabetes does not appear to be directly related to feetal survival; the same can be said of the age at onset and the duration of the disease. In our experience foetal loss cannot be attributed to any large extent to toxaemia of pregnancy. In 1942 Lawrence and I published the results of a series of 54 diabetic pregnancies and drew attention to the striking relationship between diabetic control and foetal survival. In the light of subsequent work it appears that in the past we have been content with too low a standard of diabetic control, and reanalysis of our results on a stricter criterion has confirmed this relationship. In a series of 109 pregnancies the foetal survival rate in patients with good diabetic control was 81 % and that in 101 patients delivered at King's College Hospital during the past three years was 86 %; if congenital deformities incompatible with life are excluded from this last series the survival rate is 89%. The difference between these figures may well be related to the fact that, for the past three years, all pregnant diabetics have been admitted to hospital at the 32nd week.
Analysis of the 12 cases of foetal loss showed that in 6 the control of the maternal diabetes, either before or after admission, was less than good, while in the remaining 6 it was good throughout pregnancy. Assuming that control of the maternal diabetes is the sole factor in determining foetal survival 6 of the 12 feetal fatalities in this series of 101 pregnancies might be accounted for, leaving 6 or 6% attributable to some other cause. It is perhaps more than a coincidence that this figure approximates closely to that given by some authors for the foetal loss rate in pre-diabetic mothers. REFERENCE 
